Team Hewins LLC Invests $566,000 in Humana Inc. (NYSE:HUM)

Team Hewins LLC acquired a new position in shares of Humana Inc. (NYSE:HUM) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,235 shares of the insurance provider’s stock, valued at approximately $566,000.

Other hedge funds also recently bought and sold shares of the company. Norges Bank bought a new position in Humana in the fourth quarter valued at about $676,800,000. Ameriprise Financial Inc. lifted its stake in shares of Humana by 35.9% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,523,835 shares of the insurance provider’s stock worth $741,409,000 after acquiring an additional 402,559 shares during the last quarter. AQR Capital Management LLC lifted its stake in shares of Humana by 39.3% during the 3rd quarter. AQR Capital Management LLC now owns 681,868 shares of the insurance provider’s stock worth $331,743,000 after acquiring an additional 192,546 shares during the last quarter. Quadrature Capital Ltd raised its position in Humana by 814.5% during the 3rd quarter. Quadrature Capital Ltd now owns 181,787 shares of the insurance provider’s stock valued at $88,448,000 after purchasing an additional 161,909 shares in the last quarter. Finally, Adage Capital Partners GP L.L.C. increased its holdings in shares of Humana by 2,659.2% in the 3rd quarter. Adage Capital Partners GP L.L.C. now owns 152,860 shares of the insurance provider’s stock valued at $74,369,000 after acquiring an additional 147,320 shares during the period. Institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Raymond James began coverage on Humana in a report on Friday, March 22nd. They issued a “market perform” rating for the company. TD Cowen cut their price objective on Humana from $427.00 to $396.00 and set a “buy” rating for the company in a research note on Tuesday, April 2nd. Oppenheimer cut their price objective on Humana from $415.00 to $370.00 and set an “outperform” rating for the company in a research note on Thursday, April 25th. Bank of America upped their price target on Humana from $342.00 to $376.00 and gave the company a “neutral” rating in a research report on Monday. Finally, UBS Group lowered their price objective on Humana from $334.00 to $326.00 and set a “neutral” rating for the company in a research report on Thursday, April 25th. Eleven analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, Humana currently has an average rating of “Hold” and a consensus target price of $426.39.

Humana Price Performance

NYSE:HUM traded down $3.33 on Friday, reaching $348.89. The stock had a trading volume of 1,241,188 shares, compared to its average volume of 1,922,345. The company has a market capitalization of $42.04 billion, a P/E ratio of 21.74, a price-to-earnings-growth ratio of 2.07 and a beta of 0.50. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $530.54. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.77. The stock has a fifty day moving average price of $323.46 and a 200-day moving average price of $372.57.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. The business had revenue of $29.61 billion during the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. Humana’s revenue for the quarter was up 10.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $9.38 earnings per share. Research analysts forecast that Humana Inc. will post 16.18 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.01%. The ex-dividend date is Friday, June 28th. Humana’s dividend payout ratio (DPR) is presently 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.